Crossmark

Hospitalization and Death in the First 30 days After Outpatient Lower Extremity Arterial Stenting

Published Online: 2022-06-22

Published Print: 2022-10

Authors

Jan, Simon

Gouëffic, Yann

Grimaud, Olivier

Le Meur, Nolwenn https://orcid.org/0000-0001-8451-4014
Funding

Funding for this research was provided by:

Agence Nationale de Sécurité du Médicament et des Produits de Santé
License Information

Text and Data Mining valid from 2022-06-22

Version of Record valid from 2022-06-22
More Information

Article History

Received: 19 January 2022

Accepted: 27 May 2022

First Online: 22 June 2022

Declarations

:

: Y. Gouëffic reports research funding from Bard, General Electric, Medtronic, WL Gore, personal fees and grants from Abbott, Bard, Biotronik, Boston Scientific, Medtronic, Penumbra, Terumo, Vygon, WL Gore (medical advisory board, educational course, speaking). None of these funds was used for the present work. The other authors declare that they have no competing interests.

: For this type of study formal consent is not required. This study was approved by the Institutional Review Board of the SNDS (agreement #201) and the National Authority Review Board for data protection (CNIL agreement #1968571).

: For this type of study informed consent is not required.

: For this type of study consent for publication is not required.

Document is current